Mindray’s TE7 Ultrasound System Crystal Series
“Through a partnership with Mindray, I have gained access to incredible life-saving technologies.” – Dr. Robert Reardon, MD of Emergency Medicine at Hennepin County Medical Center, Minnesota’s first Level 1 Trauma Center
MAHWAH, N.J. (PRWEB)
October 23, 2019
Mindray, a global developer of technologies and solutions for patient monitoring, anesthesia and ultrasound, today announced they will be attending the American College of Emergency Physicians (ACEP) 2019 Scientific Assembly to highlight their advanced cardiac capabilities. ACEP, the world’s largest emergency medicine conference, will take place from October 27-30 in Denver, Colorado. Mindray will feature live scanning and an in-booth presentation on Tissue Tracking technology by Dr. Robert Reardon, MD of Emergency Medicine at Hennepin County Medical Center, Minnesota’s first Level 1 Trauma Center. All ACEP attendees are invited to visit exhibit #221 to learn more about Mindray’s complete range of advanced emergency medicine solutions.
Over the past 20 years, ultrasound has become an integral part of emergency departments, particularly for use with patients experiencing cardiac arrest. At the ACEP Scientific Assembly, Mindray will highlight its three primary point-of-care ultrasound systems, TE7, M9 and ZS3, each of which is equipped with advanced cardiac capabilities and transesophageal echocardiography (TEE) technology.
According to the American College of Emergency Physicians, “ultrasound has been shown in cardiac arrest to accurately identify the presence or lack of intrinsic cardiac activity and in some cases the cause of arrest, including left ventricular failure, right ventricular failure, pulmonary embolism, pericardial tamponade, and hypovolemia¹.” The College also observed that TEE allows emergency physicians to continuously monitor the patient without interrupting chest compressions during a cardiac arrest¹.
Mindray’s advanced single crystal transducers with 3T technology™ allow the end-user to scan at higher frequencies without the loss of penetration, thus bringing large cart-based image resolution to the point-of-care setting. Accompanying Tissue Tracking technology with quantitative analysis allows users to monitor the displacement of cardiac tissue by tracking the speckle displacement in the image from frame to frame. This advanced technology brings quantitative cardiac dysfunction assessment tools to the bedside.
“Through a partnership with Mindray, I have gained access to incredible life-saving technologies,” says Dr. Reardon. “I am passionate about assuring that every one of my patients receives the highest quality emergency care, and Mindray’s ultrasound systems empower me to provide care above and beyond the industry standard. Their mission to put healthcare within reach is evident in all that they do to support my team and me.”
Also on display will be Mindray’s new BeneVision N-Series Patient Monitoring Platform, the first-ever patient monitoring platform to incorporate capacitive touchscreen technology across all of its monitors. Using its unique multi-gesture touch and swipe control, similar to a smart device, clinicians can cut minutes off of clinical review, analysis and charting time. Applying the same user interface across the entire suite, N-Series supports unprecedented usability and clinical proficiency. Additionally, with the clever N1 3-in-1 monitor at the core, serving as both monitor and module and with wireless capability, N1 provides gap-free monitoring from the point of admission to discharge.
Visit ACEP exhibit #221 to see all that Mindray North America can offer an emergency department.
Mindray is a leading developer, manufacturer and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, In Vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.
[1] American College of Emergency Physicians. (207, April). Guidelines for the Use of Transesophageal Echocardiography (TEE) in the ED for Cardiac Arrest [Policy Statement]. Retrieved from https://www.acep.org/globalassets/new-pdfs/policy-statements/guidelines-for-the-use-of-transesophogeal-echocardiography-in-the-ed-for-cardiac-arrest.pdf
Share article on social media or email: